non-serious. Results from this study will help regulators make decisions about whether
to approve botulinum toxin type A for the treatment of urinary incontinence due to
NDO in Japanese patients.
Are there plans for further studies?
No further studies are planned at this time.
Where can I find more information about this study?
Clinical studies have unique study numbers that are included in publications and other
information about the study. The unique study number associated with this study is
shown below with an internet link to the scientific summary and other information.
The scientific summary includes more details about the requirements for study
enrolment, the study visit schedule, results from other endpoints, and more detailed
information about adverse events.
Organisation Website Study Number
United States National
www.clinicaltrials.gov NCT028494181
Institutes of Health (NIH)
Your doctor can help you understand more about this study and the results. Speak to
your doctor about the treatment options available in your country. You should not
make changes to your care based on the results of this or any single study. Keep taking
your current treatment unless instructed by your doctor.
We would like to thank the patients who contributed to this study. The results of this
study will help answer scientific questions about treating patients with urinary
incontinence due to NDO.
The content for this document was finalised by GSK on the 14th of October 2019. The
information in this summary does not include additional information available after this
date.
1https://clinicaltrials.gov/ct2/show/study/NCT02849418